VereFever™ is able to detect, differentiate and identify 7 different major tropical diseases from a single blood sample, including Malaria, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis and Zika by using the STMicroelectronics proprietary Lab-on-Chip platform that integrates two powerful molecular biological applications, Polymerase Chain Reaction (PCR) and a microarray.
The Agri-Food and Veterinary Authority of Singapore (AVA) and Veredus Laboratories has jointly launched VereVet™, a portable Lab-on-Chip application that is able to detect, differentiate and identify nine major poultry infectious disease agents from one sample in one single test.
VerePLEX™ Biosystem has been selected by the Brazilian civil security forces as a system to monitor and identify potential biological threats during the FIFA World Cup 2014.
Veredus has successfully developed VereMERS™, a Lab-on-Chip application that is able to detect, from a sequence perspective, Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
The Agency for Science, Technology and Research (A*STAR) and VeredusLaboratories announced the launch of VereTrop™, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases, from a single blood sample.
The current version of VereFlu detects the current subtype of H7N9 (Avian Flu) that is responsible for the Flu outbreak in China. H7N9 is the latest mutation to cause concern and increased surveillance in the region.
VereMTB™, a multiplexed molecular diagnostic chip capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and MDR-TB, as well as 9 other clinically relevant non-tubercular mycobacterium.
June 23, 2011
VereFoodborne™, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, was launched today.
July 6, 2009
The VereFlu™ chip, based on STMicroelectronics’s lab-on-chip platform, is a portable lab-on-chip application that can identify and differentiate human strains of Influenza A and B viruses in a single test with high accuracy and sensitivity. VereFlu™ chip has been tested successfully on confirmed pandemic H1N1-2009 influenza positive samples in a joint trial with the National Public Health Laboratory (NPHL).
April 29, 2009
Veredus Laboratories today announced that the current version of VereFlu™ is able to detect, from a sequence perspective, the variant strain of H1N1 (swine flu) that is responsible for the Flu outbreak in Mexico.